Its advanced technologies not simply find to remodel procedure paradigms in cancer therapy but will also increase to addressing infectious disorders, thereby broadening its likely marketplace impact.With a robust medical-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, for instance Retrocyte Display™ and SECANT®,